[Anti-citrullinated peptides antibodies. New markers of rheumatoid arthritis]
Archives de l'Institut Pasteur de Tunis. 2006; 83 (1-4): 13-17
em Francês
| IMEMR
| ID: emr-76074
ABSTRACT
Rheumatoid arthritis is a multi-factorial autoimmune disease in which patho-physiological mechanisms have been partially elucidated these past few years. These recent advances have led to new and effective treatments that must be started early in the course of the disease. This review focuses on new serological markers, the anti citrullinated peptides antibodies which seem to be useful in early diagnosis and prognosis of rheumatoid arthritis and probably provide new insights in its pathogenesis
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Assunto principal:
Artrite Reumatoide
/
Autoanticorpos
/
Biomarcadores
/
Citrulina
Tipo de estudo:
Estudo de rastreamento
Limite:
Humanos
Idioma:
Francês
Revista:
Arch. Inst. Pasteur Tunis
Ano de publicação:
2006
Similares
MEDLINE
...
LILACS
LIS